For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Lung hyperinflation and less yawning are among the physical changes that can accompany COPD, columnist Caroline Gainer writes ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... treat patients with opioids such as morphine to relieve symptoms, but there has been a lack of evidence as to whether this helps ...

HealthDay News — Convolutional neural network (CNN)-based chronic obstructive pulmonary disease (COPD) diagnosis and staging using single-phase computed tomography (CT) has accuracy comparable to ...

COPD health risks: Chronic obstructive pulmonary disease (COPD) is a serious health condition that affects the lungs, and also poses a risk to a person's overall well-being. This disease raises ...

the best thing you can do to keep your asthma and COPD symptoms under control is to plan and be prepared for an increase in triggers, to advocate for yourself, and discuss with your healthcare ...